nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—Hydroxyurea—brain cancer	0.77	1	CbGbCtD
Fludarabine—RRM1—E2F transcription factor network—HIC1—brain cancer	0.00313	0.0684	CbGpPWpGaD
Fludarabine—Azacitidine—DNMT1—brain cancer	0.00232	0.691	CrCbGaD
Fludarabine—POLA1—E2F transcription factor network—HIC1—brain cancer	0.00176	0.0385	CbGpPWpGaD
Fludarabine—POLA1—Leading Strand Synthesis—PCNA—brain cancer	0.00124	0.027	CbGpPWpGaD
Fludarabine—POLA1—Removal of the Flap Intermediate—PCNA—brain cancer	0.00124	0.027	CbGpPWpGaD
Fludarabine—POLA1—G1/S-Specific Transcription—CCNE1—brain cancer	0.00119	0.0261	CbGpPWpGaD
Fludarabine—POLA1—pituitary gland—brain cancer	0.00114	0.0503	CbGeAlD
Fludarabine—POLA1—Processive synthesis on the lagging strand—PCNA—brain cancer	0.00111	0.0243	CbGpPWpGaD
Fludarabine—RRM1—telencephalon—brain cancer	0.00111	0.049	CbGeAlD
Fludarabine—POLA1—G1/S-Specific Transcription—PCNA—brain cancer	0.00106	0.0231	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ALK—brain cancer	0.00103	0.309	CrCbGaD
Fludarabine—RRM1—gonad—brain cancer	0.000925	0.0409	CbGeAlD
Fludarabine—RRM1—pituitary gland—brain cancer	0.000902	0.0399	CbGeAlD
Fludarabine—SLC29A1—telencephalon—brain cancer	0.000901	0.0399	CbGeAlD
Fludarabine—POLA1—Lagging Strand Synthesis—PCNA—brain cancer	0.000893	0.0195	CbGpPWpGaD
Fludarabine—RRM1—medulla oblongata—brain cancer	0.00087	0.0385	CbGeAlD
Fludarabine—DCK—telencephalon—brain cancer	0.00086	0.0381	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000855	0.0187	CbGpPWpGaD
Fludarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—brain cancer	0.000831	0.0182	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000804	0.0176	CbGpPWpGaD
Fludarabine—RRM1—midbrain—brain cancer	0.000796	0.0352	CbGeAlD
Fludarabine—RRM1—spinal cord—brain cancer	0.000776	0.0343	CbGeAlD
Fludarabine—POLA1—cerebellum—brain cancer	0.000775	0.0343	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000762	0.0167	CbGpPWpGaD
Fludarabine—SLC29A1—gonad—brain cancer	0.000752	0.0333	CbGeAlD
Fludarabine—SLC29A1—pituitary gland—brain cancer	0.000733	0.0325	CbGeAlD
Fludarabine—DCK—gonad—brain cancer	0.000718	0.0318	CbGeAlD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000702	0.0154	CbGpPWpGaD
Fludarabine—DCK—pituitary gland—brain cancer	0.000701	0.031	CbGeAlD
Fludarabine—RRM1—endocrine gland—brain cancer	0.000699	0.0309	CbGeAlD
Fludarabine—POLA1—Extension of Telomeres—PCNA—brain cancer	0.00069	0.0151	CbGpPWpGaD
Fludarabine—RRM1—head—brain cancer	0.00069	0.0305	CbGeAlD
Fludarabine—DCK—medulla oblongata—brain cancer	0.000676	0.0299	CbGeAlD
Fludarabine—RRM1—E2F transcription factor network—SIRT1—brain cancer	0.000669	0.0146	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CCNE1—brain cancer	0.000661	0.0145	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000658	0.0144	CbGpPWpGaD
Fludarabine—POLA1—DNA strand elongation—PCNA—brain cancer	0.000638	0.0139	CbGpPWpGaD
Fludarabine—POLA1—brain—brain cancer	0.00063	0.0279	CbGeAlD
Fludarabine—RRM1—central nervous system—brain cancer	0.00063	0.0279	CbGeAlD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.000622	0.0136	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000619	0.0135	CbGpPWpGaD
Fludarabine—DCK—midbrain—brain cancer	0.000618	0.0273	CbGeAlD
Fludarabine—RRM1—cerebellum—brain cancer	0.000615	0.0272	CbGeAlD
Fludarabine—DCK—spinal cord—brain cancer	0.000603	0.0267	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000587	0.0128	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000574	0.0126	CbGpPWpGaD
Fludarabine—SLC29A1—endocrine gland—brain cancer	0.000568	0.0251	CbGeAlD
Fludarabine—SLC29A1—head—brain cancer	0.000561	0.0248	CbGeAlD
Fludarabine—Pneumonia—Procarbazine—brain cancer	0.000554	0.00351	CcSEcCtD
Fludarabine—Sensory loss—Etoposide—brain cancer	0.00055	0.00348	CcSEcCtD
Fludarabine—Infection—Lomustine—brain cancer	0.00055	0.00348	CcSEcCtD
Fludarabine—DCK—endocrine gland—brain cancer	0.000543	0.024	CbGeAlD
Fludarabine—Thrombocytopenia—Lomustine—brain cancer	0.000542	0.00343	CcSEcCtD
Fludarabine—Pain—Carboplatin—brain cancer	0.000541	0.00342	CcSEcCtD
Fludarabine—Neuropathy peripheral—Procarbazine—brain cancer	0.00054	0.00342	CcSEcCtD
Fludarabine—Stomatitis—Procarbazine—brain cancer	0.000537	0.0034	CcSEcCtD
Fludarabine—DCK—head—brain cancer	0.000536	0.0237	CbGeAlD
Fludarabine—Anorexia—Lomustine—brain cancer	0.000527	0.00334	CcSEcCtD
Fludarabine—Haematuria—Procarbazine—brain cancer	0.000525	0.00332	CcSEcCtD
Fludarabine—Epistaxis—Procarbazine—brain cancer	0.000519	0.00329	CcSEcCtD
Fludarabine—Phlebitis—Carmustine—brain cancer	0.000519	0.00328	CcSEcCtD
Fludarabine—Hyperuricaemia—Etoposide—brain cancer	0.000513	0.00325	CcSEcCtD
Fludarabine—POLA1—DNA Replication—PCNA—brain cancer	0.000513	0.0112	CbGpPWpGaD
Fludarabine—SLC29A1—central nervous system—brain cancer	0.000512	0.0227	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000509	0.0111	CbGpPWpGaD
Fludarabine—SLC29A1—cerebellum—brain cancer	0.0005	0.0221	CbGeAlD
Fludarabine—Body temperature increased—Carboplatin—brain cancer	0.0005	0.00316	CcSEcCtD
Fludarabine—RRM1—brain—brain cancer	0.0005	0.0221	CbGeAlD
Fludarabine—Haemoglobin—Procarbazine—brain cancer	0.000497	0.00314	CcSEcCtD
Fludarabine—Haemorrhage—Procarbazine—brain cancer	0.000494	0.00313	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000489	0.0107	CbGpPWpGaD
Fludarabine—DCK—central nervous system—brain cancer	0.000489	0.0216	CbGeAlD
Fludarabine—Blood uric acid increased—Etoposide—brain cancer	0.000485	0.00307	CcSEcCtD
Fludarabine—Deafness—Temozolomide—brain cancer	0.000483	0.00306	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000482	0.0105	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000481	0.0105	CbGpPWpGaD
Fludarabine—Decreased appetite—Lomustine—brain cancer	0.000481	0.00304	CcSEcCtD
Fludarabine—Hepatic failure—Temozolomide—brain cancer	0.000481	0.00304	CcSEcCtD
Fludarabine—DCK—cerebellum—brain cancer	0.000478	0.0212	CbGeAlD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000456	0.00997	CbGpPWpGaD
Fludarabine—Pancytopenia—Hydroxyurea—brain cancer	0.000454	0.00287	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000453	0.00991	CbGpPWpGaD
Fludarabine—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000447	0.00283	CcSEcCtD
Fludarabine—Neutropenia—Hydroxyurea—brain cancer	0.000447	0.00283	CcSEcCtD
Fludarabine—Dysuria—Hydroxyurea—brain cancer	0.000447	0.00283	CcSEcCtD
Fludarabine—Chills—Procarbazine—brain cancer	0.000444	0.00281	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000442	0.00966	CbGpPWpGaD
Fludarabine—Arrhythmia—Procarbazine—brain cancer	0.000442	0.00279	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00044	0.00962	CbGpPWpGaD
Fludarabine—Body temperature increased—Lomustine—brain cancer	0.000437	0.00277	CcSEcCtD
Fludarabine—Alopecia—Procarbazine—brain cancer	0.000437	0.00276	CcSEcCtD
Fludarabine—Oesophagitis—Etoposide—brain cancer	0.000435	0.00275	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000429	0.00939	CbGpPWpGaD
Fludarabine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000418	0.00264	CcSEcCtD
Fludarabine—Stomatitis—Hydroxyurea—brain cancer	0.000415	0.00263	CcSEcCtD
Fludarabine—Liver function test abnormal—Carmustine—brain cancer	0.000413	0.00261	CcSEcCtD
Fludarabine—SLC29A1—brain—brain cancer	0.000406	0.018	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—brain cancer	0.000406	0.00888	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—SKP2—brain cancer	0.000402	0.0088	CbGpPWpGaD
Fludarabine—Dehydration—Temozolomide—brain cancer	0.000402	0.00254	CcSEcCtD
Fludarabine—Phlebitis—Etoposide—brain cancer	0.000401	0.00254	CcSEcCtD
Fludarabine—Anaemia—Procarbazine—brain cancer	0.000398	0.00252	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000391	0.00856	CbGpPWpGaD
Fludarabine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000389	0.00246	CcSEcCtD
Fludarabine—DCK—brain—brain cancer	0.000388	0.0172	CbGeAlD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—brain cancer	0.000387	0.00846	CbGpPWpGaD
Fludarabine—Dysphagia—Carmustine—brain cancer	0.000386	0.00245	CcSEcCtD
Fludarabine—Leukopenia—Procarbazine—brain cancer	0.000385	0.00244	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000385	0.00842	CbGpPWpGaD
Fludarabine—Haemoglobin—Hydroxyurea—brain cancer	0.000385	0.00243	CcSEcCtD
Fludarabine—Haemorrhage—Hydroxyurea—brain cancer	0.000383	0.00242	CcSEcCtD
Fludarabine—Cardiac failure congestive—Etoposide—brain cancer	0.000381	0.00241	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—SIRT1—brain cancer	0.000377	0.00824	CbGpPWpGaD
Fludarabine—Cough—Procarbazine—brain cancer	0.000376	0.00238	CcSEcCtD
Fludarabine—Dysphagia—Temozolomide—brain cancer	0.000373	0.00236	CcSEcCtD
Fludarabine—Convulsion—Procarbazine—brain cancer	0.000373	0.00236	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CCNE1—brain cancer	0.000372	0.00814	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—brain cancer	0.000372	0.00813	CbGpPWpGaD
Fludarabine—Pancytopenia—Carmustine—brain cancer	0.000367	0.00232	CcSEcCtD
Fludarabine—Myalgia—Procarbazine—brain cancer	0.000366	0.00232	CcSEcCtD
Fludarabine—Arthralgia—Procarbazine—brain cancer	0.000366	0.00232	CcSEcCtD
Fludarabine—POLA1—S Phase—SKP2—brain cancer	0.000365	0.00799	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000365	0.00798	CbGpPWpGaD
Fludarabine—Sweating increased—Temozolomide—brain cancer	0.000364	0.0023	CcSEcCtD
Fludarabine—Neutropenia—Carmustine—brain cancer	0.000361	0.00229	CcSEcCtD
Fludarabine—Bronchitis—Temozolomide—brain cancer	0.000359	0.00227	CcSEcCtD
Fludarabine—Pancytopenia—Temozolomide—brain cancer	0.000355	0.00224	CcSEcCtD
Fludarabine—Cardiac failure—Etoposide—brain cancer	0.000354	0.00224	CcSEcCtD
Fludarabine—Confusional state—Procarbazine—brain cancer	0.000354	0.00224	CcSEcCtD
Fludarabine—Vomiting—Lomustine—brain cancer	0.000352	0.00223	CcSEcCtD
Fludarabine—Oedema—Procarbazine—brain cancer	0.000351	0.00222	CcSEcCtD
Fludarabine—Dysuria—Temozolomide—brain cancer	0.000349	0.00221	CcSEcCtD
Fludarabine—Neutropenia—Temozolomide—brain cancer	0.000349	0.00221	CcSEcCtD
Fludarabine—Infection—Procarbazine—brain cancer	0.000349	0.00221	CcSEcCtD
Fludarabine—Hyperglycaemia—Carmustine—brain cancer	0.000349	0.00221	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000347	0.0022	CcSEcCtD
Fludarabine—Pneumonia—Carmustine—brain cancer	0.000347	0.00219	CcSEcCtD
Fludarabine—Thrombocytopenia—Procarbazine—brain cancer	0.000344	0.00218	CcSEcCtD
Fludarabine—Chills—Hydroxyurea—brain cancer	0.000343	0.00217	CcSEcCtD
Fludarabine—Hyperhidrosis—Procarbazine—brain cancer	0.00034	0.00215	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000339	0.00741	CbGpPWpGaD
Fludarabine—Renal failure—Carmustine—brain cancer	0.000339	0.00214	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000338	0.0074	CbGpPWpGaD
Fludarabine—Alopecia—Hydroxyurea—brain cancer	0.000338	0.00214	CcSEcCtD
Fludarabine—Neuropathy peripheral—Carmustine—brain cancer	0.000338	0.00214	CcSEcCtD
Fludarabine—Hyperglycaemia—Temozolomide—brain cancer	0.000337	0.00213	CcSEcCtD
Fludarabine—Stomatitis—Carmustine—brain cancer	0.000336	0.00213	CcSEcCtD
Fludarabine—Urinary tract infection—Carmustine—brain cancer	0.000335	0.00212	CcSEcCtD
Fludarabine—Pneumonia—Temozolomide—brain cancer	0.000335	0.00212	CcSEcCtD
Fludarabine—Anorexia—Procarbazine—brain cancer	0.000335	0.00212	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00033	0.00209	CcSEcCtD
Fludarabine—Nausea—Lomustine—brain cancer	0.000329	0.00208	CcSEcCtD
Fludarabine—Neuropathy peripheral—Temozolomide—brain cancer	0.000326	0.00207	CcSEcCtD
Fludarabine—Stomatitis—Temozolomide—brain cancer	0.000325	0.00205	CcSEcCtD
Fludarabine—Urinary tract infection—Temozolomide—brain cancer	0.000324	0.00205	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000323	0.00707	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00032	0.00203	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000316	0.00691	CbGpPWpGaD
Fludarabine—Paraesthesia—Procarbazine—brain cancer	0.000315	0.002	CcSEcCtD
Fludarabine—POLA1—Telomere Maintenance—PCNA—brain cancer	0.000313	0.00684	CbGpPWpGaD
Fludarabine—Sinusitis—Temozolomide—brain cancer	0.000312	0.00198	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000311	0.00197	CcSEcCtD
Fludarabine—Haemoglobin—Carmustine—brain cancer	0.000311	0.00197	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00031	0.00678	CbGpPWpGaD
Fludarabine—Haemorrhage—Carmustine—brain cancer	0.000309	0.00196	CcSEcCtD
Fludarabine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000309	0.00196	CcSEcCtD
Fludarabine—Anaemia—Hydroxyurea—brain cancer	0.000308	0.00195	CcSEcCtD
Fludarabine—Hypoaesthesia—Carmustine—brain cancer	0.000308	0.00195	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000306	0.00669	CbGpPWpGaD
Fludarabine—Decreased appetite—Procarbazine—brain cancer	0.000305	0.00193	CcSEcCtD
Fludarabine—Fatigue—Procarbazine—brain cancer	0.000303	0.00192	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000302	0.00661	CbGpPWpGaD
Fludarabine—Haemoglobin—Temozolomide—brain cancer	0.0003	0.0019	CcSEcCtD
Fludarabine—Malaise—Hydroxyurea—brain cancer	0.0003	0.0019	CcSEcCtD
Fludarabine—Pain—Procarbazine—brain cancer	0.0003	0.0019	CcSEcCtD
Fludarabine—Constipation—Procarbazine—brain cancer	0.0003	0.0019	CcSEcCtD
Fludarabine—Haemorrhage—Temozolomide—brain cancer	0.000299	0.00189	CcSEcCtD
Fludarabine—Dysphagia—Etoposide—brain cancer	0.000299	0.00189	CcSEcCtD
Fludarabine—Leukopenia—Hydroxyurea—brain cancer	0.000298	0.00189	CcSEcCtD
Fludarabine—Visual impairment—Carmustine—brain cancer	0.000298	0.00189	CcSEcCtD
Fludarabine—Hypoaesthesia—Temozolomide—brain cancer	0.000297	0.00188	CcSEcCtD
Fludarabine—Pharyngitis—Temozolomide—brain cancer	0.000297	0.00188	CcSEcCtD
Fludarabine—Sweating increased—Etoposide—brain cancer	0.000291	0.00184	CcSEcCtD
Fludarabine—Feeling abnormal—Procarbazine—brain cancer	0.000289	0.00183	CcSEcCtD
Fludarabine—Convulsion—Hydroxyurea—brain cancer	0.000289	0.00183	CcSEcCtD
Fludarabine—Visual impairment—Temozolomide—brain cancer	0.000288	0.00182	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000287	0.00627	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000285	0.00622	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000284	0.00621	CbGpPWpGaD
Fludarabine—Pancytopenia—Etoposide—brain cancer	0.000284	0.0018	CcSEcCtD
Fludarabine—Erythema multiforme—Temozolomide—brain cancer	0.000283	0.00179	CcSEcCtD
Fludarabine—Discomfort—Hydroxyurea—brain cancer	0.00028	0.00177	CcSEcCtD
Fludarabine—Neutropenia—Etoposide—brain cancer	0.000279	0.00177	CcSEcCtD
Fludarabine—Body temperature increased—Procarbazine—brain cancer	0.000278	0.00176	CcSEcCtD
Fludarabine—Arrhythmia—Carmustine—brain cancer	0.000276	0.00175	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000274	0.00599	CbGpPWpGaD
Fludarabine—Alopecia—Carmustine—brain cancer	0.000273	0.00173	CcSEcCtD
Fludarabine—Oedema—Hydroxyurea—brain cancer	0.000272	0.00172	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000271	0.00593	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000271	0.00593	CbGpPWpGaD
Fludarabine—Infection—Hydroxyurea—brain cancer	0.00027	0.00171	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CCNE1—brain cancer	0.00027	0.00591	CbGpPWpGaD
Fludarabine—Malnutrition—Carmustine—brain cancer	0.000269	0.0017	CcSEcCtD
Fludarabine—Chills—Temozolomide—brain cancer	0.000268	0.0017	CcSEcCtD
Fludarabine—Pneumonia—Etoposide—brain cancer	0.000268	0.0017	CcSEcCtD
Fludarabine—Nervous system disorder—Hydroxyurea—brain cancer	0.000267	0.00169	CcSEcCtD
Fludarabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000266	0.00168	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—PCNA—brain cancer	0.000265	0.00579	CbGpPWpGaD
Fludarabine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000264	0.00167	CcSEcCtD
Fludarabine—Alopecia—Temozolomide—brain cancer	0.000264	0.00167	CcSEcCtD
Fludarabine—Acute coronary syndrome—Etoposide—brain cancer	0.000263	0.00166	CcSEcCtD
Fludarabine—RRM1—E2F transcription factor network—MYC—brain cancer	0.000262	0.00573	CbGpPWpGaD
Fludarabine—Renal failure—Etoposide—brain cancer	0.000262	0.00166	CcSEcCtD
Fludarabine—Myocardial infarction—Etoposide—brain cancer	0.000261	0.00165	CcSEcCtD
Fludarabine—Neuropathy peripheral—Etoposide—brain cancer	0.000261	0.00165	CcSEcCtD
Fludarabine—POLA1—Chromosome Maintenance—PCNA—brain cancer	0.00026	0.0057	CbGpPWpGaD
Fludarabine—Malnutrition—Temozolomide—brain cancer	0.00026	0.00165	CcSEcCtD
Fludarabine—Stomatitis—Etoposide—brain cancer	0.00026	0.00164	CcSEcCtD
Fludarabine—Anorexia—Hydroxyurea—brain cancer	0.000259	0.00164	CcSEcCtD
Fludarabine—Hypersensitivity—Procarbazine—brain cancer	0.000259	0.00164	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000257	0.00562	CbGpPWpGaD
Fludarabine—Asthenia—Procarbazine—brain cancer	0.000252	0.00159	CcSEcCtD
Fludarabine—Anaemia—Carmustine—brain cancer	0.000249	0.00157	CcSEcCtD
Fludarabine—Pruritus—Procarbazine—brain cancer	0.000249	0.00157	CcSEcCtD
Fludarabine—POLA1—DNA Replication—PCNA—brain cancer	0.000248	0.00543	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000248	0.00542	CbGpPWpGaD
Fludarabine—Agitation—Carmustine—brain cancer	0.000247	0.00157	CcSEcCtD
Fludarabine—POLA1—S Phase—CCNE1—brain cancer	0.000245	0.00536	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PPP1R12A—brain cancer	0.000245	0.00536	CbGpPWpGaD
Fludarabine—Dyspnoea—Hydroxyurea—brain cancer	0.000242	0.00153	CcSEcCtD
Fludarabine—Ill-defined disorder—Temozolomide—brain cancer	0.000241	0.00153	CcSEcCtD
Fludarabine—Leukopenia—Carmustine—brain cancer	0.000241	0.00153	CcSEcCtD
Fludarabine—Anaemia—Temozolomide—brain cancer	0.000241	0.00152	CcSEcCtD
Fludarabine—Diarrhoea—Procarbazine—brain cancer	0.00024	0.00152	CcSEcCtD
Fludarabine—Dyspepsia—Hydroxyurea—brain cancer	0.000239	0.00151	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—PCNA—brain cancer	0.000239	0.00523	CbGpPWpGaD
Fludarabine—Agitation—Temozolomide—brain cancer	0.000239	0.00151	CcSEcCtD
Fludarabine—Hypoaesthesia—Etoposide—brain cancer	0.000238	0.00151	CcSEcCtD
Fludarabine—Decreased appetite—Hydroxyurea—brain cancer	0.000236	0.0015	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000235	0.00149	CcSEcCtD
Fludarabine—Malaise—Temozolomide—brain cancer	0.000235	0.00148	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000234	0.00513	CbGpPWpGaD
Fludarabine—Fatigue—Hydroxyurea—brain cancer	0.000234	0.00148	CcSEcCtD
Fludarabine—Convulsion—Carmustine—brain cancer	0.000233	0.00148	CcSEcCtD
Fludarabine—Leukopenia—Temozolomide—brain cancer	0.000233	0.00147	CcSEcCtD
Fludarabine—Pain—Hydroxyurea—brain cancer	0.000232	0.00147	CcSEcCtD
Fludarabine—Constipation—Hydroxyurea—brain cancer	0.000232	0.00147	CcSEcCtD
Fludarabine—Myalgia—Carmustine—brain cancer	0.000229	0.00145	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000228	0.00498	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000228	0.00498	CbGpPWpGaD
Fludarabine—Cough—Temozolomide—brain cancer	0.000227	0.00144	CcSEcCtD
Fludarabine—Erythema multiforme—Etoposide—brain cancer	0.000226	0.00143	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000226	0.00494	CbGpPWpGaD
Fludarabine—Convulsion—Temozolomide—brain cancer	0.000225	0.00143	CcSEcCtD
Fludarabine—Feeling abnormal—Hydroxyurea—brain cancer	0.000224	0.00142	CcSEcCtD
Fludarabine—Vomiting—Procarbazine—brain cancer	0.000223	0.00141	CcSEcCtD
Fludarabine—Confusional state—Carmustine—brain cancer	0.000222	0.0014	CcSEcCtD
Fludarabine—Myalgia—Temozolomide—brain cancer	0.000222	0.0014	CcSEcCtD
Fludarabine—Arthralgia—Temozolomide—brain cancer	0.000222	0.0014	CcSEcCtD
Fludarabine—Rash—Procarbazine—brain cancer	0.000221	0.0014	CcSEcCtD
Fludarabine—Dermatitis—Procarbazine—brain cancer	0.000221	0.0014	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000221	0.00483	CbGpPWpGaD
Fludarabine—Headache—Procarbazine—brain cancer	0.00022	0.00139	CcSEcCtD
Fludarabine—Oedema—Carmustine—brain cancer	0.00022	0.00139	CcSEcCtD
Fludarabine—Discomfort—Temozolomide—brain cancer	0.000219	0.00139	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000219	0.00478	CbGpPWpGaD
Fludarabine—Infection—Carmustine—brain cancer	0.000218	0.00138	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—brain cancer	0.000218	0.00476	CbGpPWpGaD
Fludarabine—POLA1—S Phase—PCNA—brain cancer	0.000217	0.00475	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000217	0.00474	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Carmustine—brain cancer	0.000215	0.00136	CcSEcCtD
Fludarabine—Body temperature increased—Hydroxyurea—brain cancer	0.000215	0.00136	CcSEcCtD
Fludarabine—Chills—Etoposide—brain cancer	0.000215	0.00136	CcSEcCtD
Fludarabine—Confusional state—Temozolomide—brain cancer	0.000214	0.00135	CcSEcCtD
Fludarabine—Anaphylactic shock—Temozolomide—brain cancer	0.000212	0.00134	CcSEcCtD
Fludarabine—Oedema—Temozolomide—brain cancer	0.000212	0.00134	CcSEcCtD
Fludarabine—Alopecia—Etoposide—brain cancer	0.000211	0.00134	CcSEcCtD
Fludarabine—Infection—Temozolomide—brain cancer	0.000211	0.00134	CcSEcCtD
Fludarabine—Anorexia—Carmustine—brain cancer	0.000209	0.00133	CcSEcCtD
Fludarabine—Nausea—Procarbazine—brain cancer	0.000209	0.00132	CcSEcCtD
Fludarabine—Nervous system disorder—Temozolomide—brain cancer	0.000208	0.00132	CcSEcCtD
Fludarabine—Thrombocytopenia—Temozolomide—brain cancer	0.000208	0.00132	CcSEcCtD
Fludarabine—Hyperhidrosis—Temozolomide—brain cancer	0.000205	0.0013	CcSEcCtD
Fludarabine—Anorexia—Temozolomide—brain cancer	0.000202	0.00128	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000202	0.00441	CbGpPWpGaD
Fludarabine—Hypersensitivity—Hydroxyurea—brain cancer	0.0002	0.00127	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.0002	0.00127	CcSEcCtD
Fludarabine—Paraesthesia—Carmustine—brain cancer	0.000197	0.00125	CcSEcCtD
Fludarabine—Dyspnoea—Carmustine—brain cancer	0.000196	0.00124	CcSEcCtD
Fludarabine—Asthenia—Hydroxyurea—brain cancer	0.000195	0.00123	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000193	0.00122	CcSEcCtD
Fludarabine—Ill-defined disorder—Etoposide—brain cancer	0.000193	0.00122	CcSEcCtD
Fludarabine—Anaemia—Etoposide—brain cancer	0.000192	0.00122	CcSEcCtD
Fludarabine—Decreased appetite—Carmustine—brain cancer	0.000191	0.00121	CcSEcCtD
Fludarabine—Paraesthesia—Temozolomide—brain cancer	0.000191	0.00121	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Carmustine—brain cancer	0.00019	0.0012	CcSEcCtD
Fludarabine—Dyspnoea—Temozolomide—brain cancer	0.000189	0.0012	CcSEcCtD
Fludarabine—Constipation—Carmustine—brain cancer	0.000188	0.00119	CcSEcCtD
Fludarabine—Pain—Carmustine—brain cancer	0.000188	0.00119	CcSEcCtD
Fludarabine—Malaise—Etoposide—brain cancer	0.000188	0.00119	CcSEcCtD
Fludarabine—POLA1—S Phase—CDK4—brain cancer	0.000188	0.00411	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000187	0.00409	CbGpPWpGaD
Fludarabine—Dyspepsia—Temozolomide—brain cancer	0.000187	0.00118	CcSEcCtD
Fludarabine—Leukopenia—Etoposide—brain cancer	0.000186	0.00118	CcSEcCtD
Fludarabine—Diarrhoea—Hydroxyurea—brain cancer	0.000186	0.00118	CcSEcCtD
Fludarabine—Decreased appetite—Temozolomide—brain cancer	0.000185	0.00117	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000183	0.00116	CcSEcCtD
Fludarabine—Fatigue—Temozolomide—brain cancer	0.000183	0.00116	CcSEcCtD
Fludarabine—Cough—Etoposide—brain cancer	0.000182	0.00115	CcSEcCtD
Fludarabine—Pain—Temozolomide—brain cancer	0.000182	0.00115	CcSEcCtD
Fludarabine—Constipation—Temozolomide—brain cancer	0.000182	0.00115	CcSEcCtD
Fludarabine—Feeling abnormal—Carmustine—brain cancer	0.000181	0.00115	CcSEcCtD
Fludarabine—Convulsion—Etoposide—brain cancer	0.00018	0.00114	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000178	0.00389	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000175	0.00383	CbGpPWpGaD
Fludarabine—Discomfort—Etoposide—brain cancer	0.000175	0.00111	CcSEcCtD
Fludarabine—Feeling abnormal—Temozolomide—brain cancer	0.000175	0.00111	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000175	0.00382	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000174	0.00381	CbGpPWpGaD
Fludarabine—Body temperature increased—Carmustine—brain cancer	0.000174	0.0011	CcSEcCtD
Fludarabine—Vomiting—Hydroxyurea—brain cancer	0.000173	0.00109	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000172	0.00377	CbGpPWpGaD
Fludarabine—Rash—Hydroxyurea—brain cancer	0.000171	0.00108	CcSEcCtD
Fludarabine—Confusional state—Etoposide—brain cancer	0.000171	0.00108	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000171	0.00375	CbGpPWpGaD
Fludarabine—Dermatitis—Hydroxyurea—brain cancer	0.000171	0.00108	CcSEcCtD
Fludarabine—Headache—Hydroxyurea—brain cancer	0.00017	0.00108	CcSEcCtD
Fludarabine—Anaphylactic shock—Etoposide—brain cancer	0.00017	0.00108	CcSEcCtD
Fludarabine—Infection—Etoposide—brain cancer	0.000169	0.00107	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000168	0.00368	CbGpPWpGaD
Fludarabine—Body temperature increased—Temozolomide—brain cancer	0.000168	0.00106	CcSEcCtD
Fludarabine—Thrombocytopenia—Etoposide—brain cancer	0.000166	0.00105	CcSEcCtD
Fludarabine—Hyperhidrosis—Etoposide—brain cancer	0.000164	0.00104	CcSEcCtD
Fludarabine—Anorexia—Etoposide—brain cancer	0.000162	0.00103	CcSEcCtD
Fludarabine—Hypersensitivity—Carmustine—brain cancer	0.000162	0.00102	CcSEcCtD
Fludarabine—Nausea—Hydroxyurea—brain cancer	0.000161	0.00102	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00016	0.00351	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.00016	0.0035	CbGpPWpGaD
Fludarabine—Asthenia—Carmustine—brain cancer	0.000158	0.000998	CcSEcCtD
Fludarabine—Hypersensitivity—Temozolomide—brain cancer	0.000156	0.00099	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2C9—brain cancer	0.000155	0.00338	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000153	0.00334	CbGpPWpGaD
Fludarabine—Paraesthesia—Etoposide—brain cancer	0.000153	0.000966	CcSEcCtD
Fludarabine—Asthenia—Temozolomide—brain cancer	0.000152	0.000964	CcSEcCtD
Fludarabine—Dyspnoea—Etoposide—brain cancer	0.000152	0.000959	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000151	0.00331	CbGpPWpGaD
Fludarabine—Diarrhoea—Carmustine—brain cancer	0.00015	0.000951	CcSEcCtD
Fludarabine—Pruritus—Temozolomide—brain cancer	0.00015	0.000951	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00015	0.00328	CbGpPWpGaD
Fludarabine—Decreased appetite—Etoposide—brain cancer	0.000148	0.000935	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—MYC—brain cancer	0.000148	0.00323	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Etoposide—brain cancer	0.000147	0.000928	CcSEcCtD
Fludarabine—Fatigue—Etoposide—brain cancer	0.000147	0.000927	CcSEcCtD
Fludarabine—Pain—Etoposide—brain cancer	0.000145	0.00092	CcSEcCtD
Fludarabine—Constipation—Etoposide—brain cancer	0.000145	0.00092	CcSEcCtD
Fludarabine—Diarrhoea—Temozolomide—brain cancer	0.000145	0.000919	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000144	0.00315	CbGpPWpGaD
Fludarabine—Feeling abnormal—Etoposide—brain cancer	0.00014	0.000886	CcSEcCtD
Fludarabine—Vomiting—Carmustine—brain cancer	0.00014	0.000884	CcSEcCtD
Fludarabine—Rash—Carmustine—brain cancer	0.000139	0.000877	CcSEcCtD
Fludarabine—Dermatitis—Carmustine—brain cancer	0.000138	0.000876	CcSEcCtD
Fludarabine—Headache—Carmustine—brain cancer	0.000138	0.000871	CcSEcCtD
Fludarabine—Vomiting—Temozolomide—brain cancer	0.000135	0.000854	CcSEcCtD
Fludarabine—Body temperature increased—Etoposide—brain cancer	0.000134	0.00085	CcSEcCtD
Fludarabine—Rash—Temozolomide—brain cancer	0.000134	0.000847	CcSEcCtD
Fludarabine—Dermatitis—Temozolomide—brain cancer	0.000134	0.000847	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000133	0.00291	CbGpPWpGaD
Fludarabine—Headache—Temozolomide—brain cancer	0.000133	0.000842	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000132	0.00289	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000132	0.00289	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—BSG—brain cancer	0.000132	0.00288	CbGpPWpGaD
Fludarabine—Nausea—Carmustine—brain cancer	0.000131	0.000826	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000128	0.00281	CbGpPWpGaD
Fludarabine—Nausea—Temozolomide—brain cancer	0.000126	0.000798	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—brain cancer	0.000125	0.000792	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—SKP2—brain cancer	0.000124	0.00272	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000124	0.00272	CbGpPWpGaD
Fludarabine—Asthenia—Etoposide—brain cancer	0.000122	0.000772	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000121	0.00266	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—brain cancer	0.000121	0.00265	CbGpPWpGaD
Fludarabine—Pruritus—Etoposide—brain cancer	0.00012	0.000761	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP2C9—brain cancer	0.000119	0.0026	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000119	0.0026	CbGpPWpGaD
Fludarabine—Diarrhoea—Etoposide—brain cancer	0.000116	0.000736	CcSEcCtD
Fludarabine—RRM1—Metabolism—IDH1—brain cancer	0.000113	0.00247	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000113	0.00246	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—SKP2—brain cancer	0.000111	0.00243	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK6—brain cancer	0.000111	0.00242	CbGpPWpGaD
Fludarabine—Vomiting—Etoposide—brain cancer	0.000108	0.000684	CcSEcCtD
Fludarabine—Rash—Etoposide—brain cancer	0.000107	0.000678	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—brain cancer	0.000107	0.00234	CbGpPWpGaD
Fludarabine—Dermatitis—Etoposide—brain cancer	0.000107	0.000677	CcSEcCtD
Fludarabine—Headache—Etoposide—brain cancer	0.000106	0.000674	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000105	0.0023	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BSG—brain cancer	0.000101	0.00221	CbGpPWpGaD
Fludarabine—Nausea—Etoposide—brain cancer	0.000101	0.000639	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.97e-05	0.00218	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK6—brain cancer	9.91e-05	0.00217	CbGpPWpGaD
Fludarabine—POLA1—S Phase—MYC—brain cancer	9.72e-05	0.00213	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.65e-05	0.00211	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—brain cancer	9.03e-05	0.00197	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO2—brain cancer	8.94e-05	0.00196	CbGpPWpGaD
Fludarabine—DCK—Metabolism—IDH1—brain cancer	8.71e-05	0.0019	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.53e-05	0.00186	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.44e-05	0.00185	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCNE1—brain cancer	8.35e-05	0.00183	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BRCA2—brain cancer	7.71e-05	0.00169	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCNE1—brain cancer	7.46e-05	0.00163	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.43e-05	0.00163	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PCNA—brain cancer	7.39e-05	0.00162	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENO2—brain cancer	6.88e-05	0.00151	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.84e-05	0.0015	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.69e-05	0.00146	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PCNA—brain cancer	6.61e-05	0.00145	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—brain cancer	6.39e-05	0.0014	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK4—brain cancer	5.71e-05	0.00125	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.62e-05	0.00123	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	4.89e-05	0.00107	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—brain cancer	4.37e-05	0.000955	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—brain cancer	4.13e-05	0.000903	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—brain cancer	4.1e-05	0.000897	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—brain cancer	3.69e-05	0.000807	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—brain cancer	3.31e-05	0.000724	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—brain cancer	3.16e-05	0.000691	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—brain cancer	2.96e-05	0.000647	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—brain cancer	2.43e-05	0.000532	CbGpPWpGaD
